Results 1 to 10 of about 24,360 (218)
Grading of Castleman Disease Histopathology with an Attention-Based Multiple Instance Learning Model [PDF]
DiagnosticsBackground/Objectives: Castleman disease is a rare cytokine-driven lymphoproliferative disorder in which lymph node histopathology provides key diagnostic information.
Muir J. Morrison +29 more
doaj +2 more sources
A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease
Biology, 2021 Simple Summary Castleman disease is a rare hematopoietic disorder with a broad spectrum of clinical presentations. Different subtypes have been described based on how many lymph nodes are involved, histologic appearance, and associated viral infections ...
Kaushik Sridhar +2 more
exaly +2 more sources
Case report: A rare case of retroperitoneal mixed type unicentric Castleman disease [PDF]
Frontiers in OncologyObjectiveTo enhance the understanding, diagnosis, and management of retroperitoneal mixed type unicentric Castleman disease.MethodsThis report describes a case of retroperitoneal mixed type unicentric Castleman disease managed at our institution.
Jiajie Zhang +5 more
doaj +2 more sources
Case of a young girl with marked bone marrow plasmacytosis
Sri Lanka Journal of Medicine, 2021 Marked plasmacytosis in the bone marrow is a rare finding in young people. If present it is secondary to an underlying disease condition. Castleman disease is a rare form of lymphoproliferative disorder. Due to its rarity, it is not frequently considered
V. C. Panditha Gunwardena +4 more
doaj +1 more source
The Lancet Regional Health - Western Pacific, 2023 Summary Background Castleman disease (CD) is a group of rare and heterogenous lymphoproliferative disorders including unicentric CD (UCD), human herpesvirus-8(HHV-8)-associated multicentric CD (HHV8-MCD), and HHV-8-negative/idiopathic multicentric CD ...
Lu Zhang +41 more
semanticscholar +1 more source
Orphanet Journal of Rare Diseases, 2023 Background There are approximately 10,000 rare diseases that affect around 30,000,000 individuals in the U.S.A., most of which do not have an FDA-approved treatment.
Ania Korsunska +3 more
doaj +1 more source
Idiopathic multicentric Castleman disease: An update in diagnosis and treatment advances.
Blood reviews, 2023 Idiopathic multicentric Castleman disease (iMCD) is a rare disease, and it is likely underdiagnosed because of the heterogeneity of clinical manifestations and laboratory findings.
E. Lang, F. van Rhee
semanticscholar +1 more source
Unicentric form of Castleman´s disease, pitfalls of diagnosis and surgical treatment
Frontiers in Oncology, 2023 Background Castleman´s disease is an extremely rare heterogenous lymphoproliferative pathology with a mostly benign behavior. It is a localized or generalized lymph node enlargement of an unknown aetiology.
J. Moláček +9 more
semanticscholar +1 more source
Nature Reviews Disease Primers, 2021 Castleman disease (CD), a heterogeneous group of disorders that share morphological features, is divided into unicentric CD and multicentric CD (MCD) according to the clinical presentation and disease course.
A. Carbone +7 more
semanticscholar +1 more source
British Journal of Haematology, 2023 Castleman disease (CD) comprises a group of rare and heterogeneous haematological disorders, including unicentric (UCD) and multicentric (MCD) forms, the latter further subdivided into HHV8‐MCD, POEMS‐MCD and idiopathic‐MCD (iMCD).
S. Pelliccia +20 more
semanticscholar +1 more source